ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Sorafenib-Based Drug Delivery Systems: Applications and Perspectives

Wang, Lingyun*; Chen, Meihuan; Ran, Xueguang; Tang, Hao; Cao, Derong广东省农业科学院
Polymers2023-6DOI: 10.3390/polym15122638
10阅读
引用收藏
分享

摘要

As a Food and Drug Administration (FDA)-approved molecular-targeted chemotherapeutic drug, sorafenib (SF) can inhibit angiogenesis and tumor cell proliferation, leading to improved patient overall survival of hepatocellular carcinoma (HCC). In addition, SF is an oral multikinase inhibitor as a single-agent therapy in renal cell carcinoma. However, the poor aqueous solubility, low bioavailability, unfavorable pharmacokinetic properties and undesirable side effects (anorexia, gastrointestinal bleeding, and severe skin toxicity, etc.) seriously limit its clinical application. To overcome these drawbacks, the entrapment of SF into nanocarriers by nanoformulations is an effective strategy, which delivers SF in a target tumor with decreased adverse effects and improved treatment efficacy. In this review, significant advances and design strategies of SF nanodelivery systems from 2012 to 2023 are summarized. The review is organized by type of carriers including natural biomacromolecule (lipid, chitosan, cyclodextrin, etc.); synthetic polymer (poly(lactic-co-glycolic acid), polyethyleneimine, brush copolymer, etc.); mesoporous silica; gold nanoparticles; and others. Co-delivery of SF and other active agents (glypican-3, hyaluronic acid, apolipoprotein peptide, folate, and superparamagnetic iron oxide nanoparticles) for targeted SF nanosystems and synergistic drug combinations are also highlighted. All these studies showed promising results for targeted treatment of HCC and other cancers by SF-based nanomedicines. The outlook, challenges and future opportunities for the development of SF-based drug delivery are presented.

学科与关键词

关键词
sorafenibmulti-kinase inhibitornanodelivery systemshepatocellular carcinoma (HCC)nano-sized carrierstumor treatment
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Polymers
发表日期
2023-06
卷期
第 15 卷, 第 12 期
页码
2638
DOI
10.3390/polym15122638
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22071065]; Natural Science Foundation of Guangdong Province [2022A1515011743]

作者

  • W

    Wang, Lingyun (通讯) (第一作者)

  • C

    Chen, Meihuan

查看全部 5 位作者收起作者
  • R

    Ran, Xueguang

    guangdong acad agr sci

  • T

    Tang, Hao

  • C

    Cao, Derong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417